Neoplasia/BPH

	Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial. Prostate Nakai Y, Onishi K, Asakawa I, Miyake M, Yamaki K, Isohashi F, Fujimoto K, Tanaka N. PMID: 41570179 [PubMed - as supplied by publisher]
	Pelvic Lymph Node Staging With PSMA PET in Prostate Cancer: Surgical Validation With Implications for Radiotherapy Planning. Prostate Ozen A, Sarikaya Z, Gur C, Ozboru D, Canat HL. PMID: 41570172 [PubMed - as supplied by publisher]
	Development and Validation of a Nomogram for Predicting Pathological Upgrading in Men With Biopsy Gleason 3â€‰+â€‰3 Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Study. Prostate Li H, Xiong S, Wang M, Liu M, Wang J, Wang J, Lv Z. PMID: 41570160 [PubMed - as supplied by publisher]
	Productivity losses and treatment cost of benign prostatic hyperplasia in Ghana. PLoS One Dadee-Seshie DS, Agbeteti SG, Kpankyaano B, Adamu AF, Adanu SK, Alhassan Y, Dalaba MA, Adanu KK. PMID: 41570021 [PubMed - indexed for MEDLINE]
	Core Stability in Women With and Without Lower Urinary Tract Symptoms: The CORE-LUTS Study. Int Urogynecol J Bennis S, Kumar A, Chatwin HV, Acevedo-Alvarez M, Choi H, Wesolowski M, Fitzgerald CM. PMID: 41569411 [PubMed - as supplied by publisher]
	First-in-class HIF-2Î± therapy in genitourinary oncology: Belzutifan from von Hippel-Lindau disease to advanced renal cell carcinoma. Cancer Chemother Pharmacol Karaman I, Erdem D, Cetin B. PMID: 41569310 [PubMed - indexed for MEDLINE]
	NF-ÎºB (p65, p50), IL-18, and IL-10 as Therapeutic Targets in Prostate Cancer and BPH: Molecular Insights into Inflammation-Driven Pathogenesis. Asian Pac J Cancer Prev Dwivedi S, Saini S, - A, Np AK, Bansal A, Sharma RS, Shekhar S, - D, Goel A, Khattri S. PMID: 41569207 [PubMed - indexed for MEDLINE]
	The Radical Prostatectomy Versus Brachytherapy for the Management of Low- and Intermediate-Risk Prostate Cancer: A Meta-Analysis of Observational Studies Focusing on Oncological Outcomes. Asian Pac J Cancer Prev Warli SM, Ikram MF, Kadar DD, Siregar GP, Prapiska FF, Laksmi LI, Tala ZZ, Siregar DI, Siregar MIS. PMID: 41569192 [PubMed - indexed for MEDLINE]
	Tumor Morphology as a Risk Factor for Muscle Invasiveness in Newly Diagnosed Bladder Cancer: A Stratified Analysis. Asian Pac J Cancer Prev Do NT, Nguyen Tung L, Nguyen Cong D, Do MT. PMID: 41569182 [PubMed - indexed for MEDLINE]
	First look at evaluation of serum angiopoietin-like 4 levels in bladder cancer: A pilot study. J Physiol Pharmacol Strojny Z, Kanikowska A, Sikora W, Lewandowska M, Sato M, Strojny M, Zuraszek-Szymanska J, Deja T, Paszynska E, Korybalska K, Breborowicz A, Witowski J, Kanikowska D. PMID: 41569057 [PubMed - indexed for MEDLINE]
	Coriandrum sativum improves prognosis in clear cell renal cell carcinoma by targeting NEK6 to modulate the immune microenvironment: a predictive study based on network pharmacology and multi-omics analysis. Artif Cells Nanomed Biotechnol Li J, Zhang Y, Wang X, Zhang P, Xu Z, Huang R, Hu H. PMID: 41568676 [PubMed - indexed for MEDLINE]
	Identification of a Cuproptosis-Related Molecular Signature for Predicting Biochemical Recurrence in Prostate Cancer. Comb Chem High Throughput Screen Chen DN, Wu XH, You Q, Zhuang RB, Ruan ZT, Zhu JM, Zheng QS, Chen YH, Wei Y, Lin XD, Xue XY. PMID: 41568495 [PubMed - as supplied by publisher]
	Overall Survival in Men 80 and Older With Intermediate-Risk Prostate Cancer Who are Treated With Dose-Escalated Radiation and Androgen Deprivation Therapy Versus Dose-Escalated Radiation Alone: A National Cancer Database Analysis. Adv Radiat Oncol Dougherty TP, Deng M, Hayes S. PMID: 41568317 [PubMed]
	Real-world efficacy and safety of disitamab vedotin monotherapy or in combination with PD-1 inhibitors in locally advanced or metastatic upper tract urothelial carcinoma: a multicenter retrospective study. Front Immunol He S, Wang C, Li X, Li C, Li D, Zhang B, Wan J, Yue Z, Wu G, Zhang S, Ma J, Shang P. PMID: 41567212 [PubMed - indexed for MEDLINE]
	Integrative transcriptomic profiling reveals subtype-specific therapeutic vulnerabilities and resistance mechanisms in prostate cancer. BMC Cancer Liu W, Kong W, Jiang S, Wei Y, Yu Z, Cao X, Yang J, Wei X, Shen L, Qin C, Zhu Q. PMID: 41566241 [PubMed - indexed for MEDLINE]
	Elevated C-reactive protein to albumin ratio is a promising predictive biomarker for prognosis in patients with renal cell carcinoma. Ann Med Xu C, Guo Y, Chen X, Liu X, Wu F, Lin S. PMID: 41566198 [PubMed - indexed for MEDLINE]
	De novo urothelial carcinoma in kidney transplant recipients: a single-center retrospective cohort study. Int Urol Nephrol Schmidt J, Lehnert M, Lichy I, Goranova I, Weinberger S, Jeutner J, Kurz L, Plage H, Schlomm T, Friedersdorff F, Peters R, Biernath N, Ralla B. PMID: 41566119 [PubMed - as supplied by publisher]
	Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective study. Sci Rep Langsenlehner T, Paal K, Thurner EM, Genser S, Sternat R, Stranz B, Renner W. PMID: 41565875 [PubMed - as supplied by publisher]
	Safety and efficacy of the Chinese surgical robotic system (EDGE MP1000 & MP2000) for robot-assisted radical prostatectomy: results from a single high-volume center. J Robot Surg Zhang Y, Xu P, Wen Y, Xu Y, Xu K, Li B, Zou J, Du W, Wang Y, Liu Y, Liang T, Xu A, Chen B. PMID: 41565874 [PubMed - indexed for MEDLINE]
	Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial. Eur Urol Oncol Zilli T, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, Campos FL, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Iturre AV, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C, Achard V, Stellamans K, Goetghebeur E, Reynders D, Ost P. PMID: 41565552 [PubMed - as supplied by publisher]

Articles 1 - 20 / 184844

Page 1 of 9243



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy